Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules.
D'Andréa G, Gal J, Mandine L, Dassonville O, Vandersteen C, Guevara N, Castillo L, Poissonnet G, Culié D, Elaldi R, Sarini J, Decotte A, Renaud C, Vergez S, Schiappa R, Chamorey E, Château Y, Bozec A.
D'Andréa G, et al. Among authors: vandersteen c.
Eur J Endocrinol. 2023 Mar 2;188(3):lvad017. doi: 10.1093/ejendo/lvad017.
Eur J Endocrinol. 2023.
PMID: 36799885